MetaADEDB 2.0 @ LMMD
Papaverine
(XQYZDYMELSJDRZ-UHFFFAOYSA-N)
Structure
SMILES
COc1ccc(cc1OC)Cc1nccc2c1cc(OC)c(c2)OC
Type(s)
Approved; Investigational
ATC code(s)
A03AD01; G04BE02; G04BE52
Molecular Formula:
C20H21NO4
Molecular Weight:
339.385
Log P:
3.8600
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
0
TPSA:
49.81
CAS Number(s):
58-74-2; 61-25-6
Synonym(s)
1.
Papaverine
2.
Cerespan
3.
Papaverine Hydrochloride
4.
Pavabid
5.
Pavatym
6.
Hydrochloride, Papaverine
External Link(s)
MeSHD010208
PubChem Compound4680
BindingDB14754
ChEBI28241
CHEMBLCHEMBL19224
DrugBankDB01113
DrugCentral2056
KEGGcpd:C06533
dr:D07425
Therapeutic Target DatabaseD0WV2S
D0NJ3V
ZINC56555
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Agonal death struggleFAERS: 1US FAERS
2Blood creatine increasedFAERS: 1US FAERS
3Blood glucose increasedFAERS: 1US FAERS
4Blood sodium increasedFAERS: 1US FAERS
5Cardiac ArrestFAERS: 1US FAERS
6Carotid pulse decreasedFAERS: 1US FAERS
7FlushingFAERS: 1SIDER
US FAERS
8HepatitisFAERS: 14029887CTD
SIDER
US FAERS
9PCO2 increasedFAERS: 1US FAERS
10PruritusFAERS: 1US FAERS
11VomitingFAERS: 1US FAERS
12Abdominal discomfortSIDER
13AnorexiaSIDER
14Aphasia8613866CTD
15Arterial Occlusive Diseases3809473
8451424
CTD
16Atrioventricular Block1422403CTD
17Blindness19901231CTD
18Bradycardia19961315CTD
19Catalepsy1033561CTD
20Cerebral Arterial Diseases9726476CTD
21Chest Pain2750660CTD
22Choroid Diseases19901231CTD
23ConstipationSIDER
24DermatitisSIDER
25DiscomfortSIDER
26Dizziness3366170CTD
27Dyskinesia, Drug-Induced1172755CTD
28Dyspareunia1296038
1719248
CTD
29Edema11549511CTD
30Erectile dysfunction

View details

CTD
31Exophthalmos19901231CTD
32Facial Nerve Diseases12513030CTD
33Facial paralysis9918178
12513030
17977279
CTD
34Feeling abnormalSIDER
35Fibrosis11549511CTD
36General discomfortSIDER
37HeadacheSIDER
38Hematoma3762853CTD
39Hemiplegia8613866CTD
40Hepatitis, Chronic3949106CTD
41Hepatomegaly28108177CTD
42Hyperemia

View details

CTD
43Hypotension

View details

CTD
44Impotence, Vasculogenic1719248
2038782
CTD
45Infarction19901231CTD
46Intracranial Embolism16283980CTD
47Intracranial Hypertension9726476CTD
48Liver Cirrhosis3949106CTD
49Long QT Syndrome

View details

CTD
50MalaiseSIDER
51Muscle Weakness3366170CTD
52Mydriasis12513030CTD
53NauseaSIDER
54Neurologic Manifestations7847211CTD
55Paresis3762853
11145478
CTD
56Postoperative Complications9918178CTD
57Priapism

View details

CTD
58Respiratory Insufficiency7847211CTD
59Sinus Arrest, Cardiac19961315CTD
60Spasm47907CTD
61Tachycardia, Ventricular

View details

CTD
62Thrombosis8451424CTD
63Torsades de Pointes2044564
2605630
CTD
64Tranquillisation excessiveSIDER
65Vasospasm, Intracranial

View details

CTD
66Ventricular Fibrillation1772671CTD
67VertigoSIDER
68Vestibulocochlear Nerve Diseases18726058CTD
69jaundice3949106CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.